Aqueous transforming growth factor-beta-i levels in rabbit eyes after excimer laser photoablation

Ophthalmologica

Volumn 211, Issue 6, 1997, Pages 380-383

  Bilgihan, Kamil ^a   Gürelik, Gökhan ^a   Okur, Hamza ^a   Bilgihan, Ayse ^a   Hasanreisoğlu, Berati ^a   Imir, Turgut ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Aqueous humor; Photorefractive keratectomy; Transforming growth factor 1

Indexed keywords

CYTOKINE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR EYE SEGMENT; AQUEOUS HUMOR; ARTICLE; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA OPACITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXCIMER LASER; EXTRACELLULAR MATRIX; LASER SURGERY; MYOPIA; NONHUMAN; RABBIT; REMISSION; WOUND HEALING;

EID: 1842300410     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000310834     Document Type: Article

References (15)

1. Pasquala LR, Dorman-Pcase ME, Lutty GA, Quigley HA. Jampel HD: Immunolocalization ofTGF-pi, TGF-p2, and TGF-133 in the anterior segment of the human eye. Invest Ophthalmol VisSci 1993;34:23-30.
2. Ohji M, Sundar Raj N, Thoft RA: Transforming growth factor beta stimulates collagen and fi-bronectin synthesis by human comeal stromal fibroblasts in vitro. Curr Eye Res 1993; 12:793- 709.
3. Jain S, Azar DT: Extracellular matrix and growth factors in comeal wound healing. Curr Opin Ophthalmol 1994;5:3-12.
4. Mishima H, Nakamura M, Murakami J, Nishida T, Otori T: Transforming growth factor-beta modulates effects of epidermal growth factor on corneal epithelial cells. Curr Eye Res 1992:11: 691-696.
5. Strelein JW, Bradley D: Analysis of immunosuppressive properties of iris and ciliary body cells and their secretory products. Invest Ophthalmol Vis Sci 1991;32:2700-2710.
6. Cousins SW, McCabe MM, Danielpour D, Strcilein JW: Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci 1991:32:2201-2211.
7. Coligan JE, Kruisbeck AM, Margulies DH, Shevach EM, Strober E: Current Protocols in Immunology. New York, Wiley, 1992, pp 711-718.
8. Tuft SJ, Gartry DS, Rawe IM, Meek KM: Pho-torefractive keratectomy: Implications of corneal wound healing. Br J Ophthalmol 1993;77: 243-247.
9. Hanna KD, Pouliquen Y, Woting GO III et al: Comeal stromal wound healing in rabbits after 193 nm excimer laser surface ablation. Arch Ophthalmol 1989;107:895-901.
10. Pallikaris IG, Síganos DS: Excimer laser in situ keratomileusis and photorefractive keratectomy for correction of high myopia. J Refract Corneal Surg 1994;10:498-510.
11. Bilgihan K, Bilgihan A, Akata F, Hasanreisoglu B, Titrkozkan N: Excimer laser comeal surgery and free oxygen radicals. Jpn J Ophthalmol 1996.40:154-157.
12. Epstein D, Fagerholm P, Nystrom HH, Tengroth B: Twenty-four month follow-up of excimer laser photorefractive keratectomy for myopia. Ophthalmology 1994;101:1558-1564.
13. Seiler T, Wollansak J: Myopic photorefractive keratectomy with the excimer laser: 1-year fol-low'-up. Ophthalmology 1991;98:1156-1163.
14. Melanie CC, O’Brart DPS, Marshall J: Do topical corticosteroids have a role following excimer laser photorefractive keratectomy? J Refract Surg 1995:11:380-387.
15. Danielpour D, Kim KY, Winokur TS, Spom MB: Differential regulation of the expression of transforming growth factor-31 and 2 by retinoic acid, epidermal growth factor, and dexametha-sone in NRK-49f and A659 cells. J Cell Physiol 1991;148:235-244.